Illumina (ILMN) Divestments (2017 - 2019)
Illumina's (ILMN) quarterly Divestments came in at $15.0 million in Q1 2019, down 94.6% quarter-over-quarter from $278.0 million in Q2 2017.
Powered by 
Analysis
Illumina (ILMN) Divestments (2017 - 2019) Analysis & Trends
Illumina (ILMN) has reported Divestments for 2 consecutive years, with $15.0 million the latest figure, recorded in Q1 2019.
- For the quarter ending Q1 2019, Divestments changed N/A year-over-year to $15.0 million; the trailing twelve-month figure through Dec 2019 stood at $15.0 million (changed N/A YoY), and the FY2019 full-year result was $15.0 million, changed N/A from the prior year.
- Divestments eased to $15.0 million in Q1 2019 per ILMN's latest filing, from $278.0 million in the prior quarter.
- Across five years, Divestments topped out at $278.0 million in Q2 2017 and bottomed at $15.0 million in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | - |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | - |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | - |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 1.42 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | - |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | - |